Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
ID: 357935Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for research on current topics in Alzheimer's disease (AD) and its related dementias (ADRD) through the R01 Clinical Trial Optional grant program. This initiative aims to support innovative research that addresses significant biomedical, social, and behavioral aspects of aging, with a focus on inclusivity and diversity in participant recruitment. Given the projected rise in expenditures for AD-related care, which could exceed $1 trillion by 2050, this funding is critical for advancing understanding and treatment of dementia-related challenges. Interested applicants can find more information and submission guidelines at the NIH grants website, with applications due by November 5, 2027, and no specific budget limits outlined.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) is issuing a funding opportunity through the Department of Health and Human Services to support research on Alzheimer's disease (AD) and related dementias (ADRD). This funding announcement encourages applications focusing on significant biomedical, social, and behavioral aspects of aging and the challenges faced by older adults. It aims to advance understanding and treatment of AD, with a particular emphasis on inclusivity and diversity in research participant recruitment. Key components include the R01 Research Project Grant, with a focus on interdisciplinary research initiated by recent NIH Alzheimer’s Summit recommendations. The opportunity is open for new, renewal, and resubmission applications, with budgets reflecting project needs but no specific limits. Eligible organizations can include educational institutions, nonprofits, and state or local governments. Applications must adhere to precise submission guidelines and emphasize compliance with the NIH Data Management and Sharing Policy. The application process includes various due dates for multiple funding cycles, with potential awards contingent upon appropriations and application merit. The program aims to address a critical public health issue, anticipating that expenditures for AD-related care could surpass $1 trillion by 2050, underlining the urgency for innovative research and collaborative solutions in combating the impending crisis of dementia as the population ages.
    Similar Opportunities
    Loading similar opportunities...